Myriad Genetics Inc
MYGN· Nasdaq
MYGNMyriad Genetics Inc
Source filing unavailable
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Revenue | $102.37M | $90.83M |
| Net Income | $27.94M | $33.25M |
| EPS Diluted | $0.31 | $0.33 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Myriad Genetics Inc · CIK 899923 · Engraved from SEC EDGAR
